Brett Graham is Chairman of the Board of Leavitt Risk Partners. Brett plays an active role in the strategy and direction of the company and forging new relationships and helping develop the company’s key external alliances
Brett currently serves as Chief Strategy Officer of Leavitt Partners and President of Leavitt Partners Affiliated Entities. Prior to joining Leavitt Partners, Brett led the operations and played a key role in the sale of a regional administrator of self-funded benefit plans. Following the transaction, he led the post-merger integration and was a member of acquiring companies’ strategy team.
Earlier in his career, he worked as a vice president at UnitedHealth Group within the Ingenix business unit. Brett joined the business development and strategic planning team and was responsible for conducting analysis on acquisitions and strategic partnerships during a period of hyper-growth. Mr. Graham moved to operations and was the business leader for Ingenix’s pricing databases where he was responsible for working with large payers to aggregate and analyze claims data. In a previous role, Brett served as a management consultant with the Boston Consulting Group where he worked with senior business leaders to develop growth strategies for Fortune 100 clients.
Brett holds a master’s degree in business administration from the Harvard Business School and a master’s of public administration and a bachelor’s in accounting from the University of Utah.
Phil Harker is President and CEO for Leavitt Risk Partners. He is responsible for the general strategy, direction, and operations of the company. He brings over 20 years of experience in the healthcare industry primarily focused on the development and implementation of shared-risk models.
Prior to joining Leavitt Risk Partners, Phil led the Client Relations organization as a Senior Vice President at Rally Health where he played a key role in the rapid growth and ultimate sale of the company.
Earlier in his career, he worked as a senior vice president at UnitedHealth Group within the Ingenix/Optum business unit. Phil was the general manager of the Underwriting and Actuarial business within Optum and later joined the business development team where he was responsible for growth and retention for multiple businesses within the company resulting in a period of hyper-growth. In a previous role, Phil served as a management consultant with Deloitte and Touche Consulting Group where he worked with senior business leaders to implement growth strategies in the healthcare industry.
Phil holds a master’s degree in business administration from the W. P. Carey School of Business at Arizona State University and a bachelor’s in electrical engineering from Brigham Young University.
Craig Omer is chief financial officer at Leavitt Risk Partners. He brings decades of financial experience to the firm and its clients.
Craig worked for 36 years as an auditing and accounting services professional, primarily at KPMG where he served as Managing Partner of the firm’s Salt Lake City office from 1997 to 2009. He has provided services to a variety of publicly traded and privately held companies, performing auditing, financial reporting, and Securities and Exchange Commission compliance services. Currently, he serves on the board of directors for Savage Companies and CRS Engineering.
His professional and civic activities include having served as Board Chairman of Junior Achievement of Utah, Board Treasurer of Habitat for Humanity, Board Treasurer of the Hispanic Chamber of Commerce, President of the Utah Association of Certified Public Accountants, member of the Brigham Young University and Weber State University National School of Accountancy Advisory Boards, member of the Utah Association of Certified Public Accountants, member of the Salt Lake Chamber of Commerce Board of Trustees and Executive Committee, and member of the American Institute of Certified Public Accountants Governing Council.
Craig graduated from University of Utah with a bachelor’s degree in accounting.
As Executive Vice President and Director of Insurance Operations, Regi applies his decades of risk management expertise to shaping the vision of LRP’s best-in-class solutions. He brings over 20 years of insurance industry experience.
Regi began his career in the insurance industry with Federated Mutual Insurance in the claims department and then moved into healthcare where he worked for several years with the prestigious Mayo Clinic. In 1995 he went to Portland, Oregon as the Director of Risk Management at Oregon Health & Science University. In 2000 he began working as an independent consultant on a variety of insurance and healthcare projects which he did up until co-founding BLIS in November of 2005. He has deep experience in the design and development of new insurance products having previously successfully launched a new line of insurance.
Adam Toronto is chief operating officer for Leavitt Risk Partners. He leads enterprise-wide operations including general management, human resources, information systems, and operational expansion initiatives.
Adam previously served as Deputy Director of Advance for Secretary Mike Leavitt at the U.S. Department of Health and Human Services (HHS). In that role, he managed domestic and international Secretarial travel campaigns for departmental initiatives such as Value Driven Health Care, Import Safety, Electronic Health Records and Health Diplomacy. He was also part of a cabinet-wide team that organized two rounds of the Strategic Economic Dialogue between the U.S. and China, involving 10 U.S. Cabinet members and Chinese counterparts.
Adam also served in the Office of the Chief of Staff at HHS, under Rich McKeown. He supported Rich in overseeing public policy and operational aspects of the largest civilian department of the federal government with a staff of 67,000 and a budget of $750 billion.
Adam received his master’s degree in business administration and bachelor’s degree in political science and economics from University of Utah.
Susan Winckler serves as General Counsel for Leavitt Risk Partners. She also oversees the corporate compliance program, conflict of interest procedures, and legal record management.
A pharmacist and attorney by training, Susan is the former chief of the staff for the U.S. Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS) and former president and CEO of the Food and Drug Law Institute, a nonprofit organization based in Washington, D.C., which provides a marketplace for discussing food and drug law issues through conferences, publications, and member interaction.
At the FDA, Susan provided integrated policy analysis and strategic consultation to the Commissioner and senior FDA officials on significant agency issues and programs, serving as the agency’s principal liaison with HHS. Ms. Winckler led the operations of the Office of Legislation (until April 2009), the Office of External Relations, Office of Public Affairs, and Office of the Executive Secretariat. She joined the FDA in September 2006 as the Director, Policy Communications, in the Office of Policy and Planning within the Office of the Commissioner, where she served as a point person for constituent communications and policy development on key issues. Immediately prior to joining the FDA, Susan served as the vice president for policy and communications and staff counsel for the American Pharmacists Association (APhA), the national professional society of pharmacists, serving as the senior lobbyist for the Association on Capitol Hill. Previous positions with the Association include group director of policy and advocacy, director of policy and legislation, director of practice affairs, and manager of special projects.
Susan is a graduate of the University of Iowa College of Pharmacy and the Georgetown University Law Center, magna cum laude. She is a Fellow of the American Pharmacists Association, a Distinguished Alumna of the University of Iowa College of Pharmacy, delivered the William A. Zellmer Lecture for the American Society of Health-System Pharmacists and named as Distinguished Young Alumna of the University of Iowa Foundation. She was elected a Trustee of the United States Pharmacopeial Convention (USP) for the 2015-2020 term, elected a Distinguished Fellow in Public Policy to the National Academies of Practice, Pharmacy Academy, and named a Woman of Distinction by Alpha Xi Delta Fraternity.